BRISTOL, Tenn. (AP) -- Pharmaceutical company Pfizer Global Supply is ending manufacturing and logistics operations at its Bristol, Tenn., facility, but the plant will continue its commercial and support operations.
Pfizer is looking to consolidate plants after purchasing Bristol-based King Pharmaceuticals. Pfizer said in a news release Wednesday they will move production of a thyroid therapy and a pain medication from the underutilized facility to other sites by 2014. The company also said it was consolidating Bristol's logistics center into Pfizer's existing distribution facility in Memphis.
The move will affect about 130 manufacturing workers and 16 workers in logistics. The plant's commercial and support operations, which currently total about 166 employees, has also recently been downsized, but will remain in Bristol, said company spokesman Rick Chambers in an e-mail.